74 companies · 127 connections
AI drug discovery · knowledge graph for target identification
| Founded | 2013 |
| HQ | Fitzrovia, London |
| Founders | Mulvany |
| Funding | $700M+ |
| Valuation | €1.5B peak |
| Team | ~69 |
Pharma partners (AstraZeneca), internal drug pipeline
COVID baricitinib discovery, delisted 2025, first London AI drug discovery company
BenevolentAI is tracked by LDN/ai as part of London's AI ecosystem. The company focuses on ai drug discovery , knowledge graph for target identification.
View on the LDN/ai interactive map →
Baseimmune · Causaly · Hologen · Isomorphic Labs
View the full ecosystem guide →